TY - CHAP M1 - Book, Section TI - Vaginal Cancer A1 - Boyd, Leslie A1 - Muggia, Franco A2 - Boyiadzis, Michael M. A2 - Fojo, Tito Y1 - 2022 N1 - T2 - Hematology-Oncology Therapy, 3e AB - EpidemiologyTable Graphic Jump Location|Download (.pdf)|PrintEpidemiologyIncidence:6230 (Estimated new cases for 2020 in the United States)Incidence of clear cell adenocarcinoma as a result of in utero diethylstilbestrol(DES) exposure estimated at 1/1000Stage at presentationLocalized33.1%Regional35.5%Deaths:Estimated 1450 in 2020Distant17.1%Median age:Squamous cell cancer (60–65 years); DES-related adenocarcinoma/clear cell (19 years)Unstaged14.3%Daling JR et al. Gynecol Oncol 2002;84:263–270Siegel R et al. CA Cancer J Clin 2020;70:7–30Surveillance, Epidemiology and End Results (SEER) Program, available from http://seer.cancer.gov [accessed in 2020]Tedeschi C et al. J Low Genit Tract Dis 2005;9:11–18 SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/03/28 UR - hemonc.mhmedical.com/content.aspx?aid=1187885584 ER -